Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroguard Safety in Laparoscopic Cholecystectomy
NCT03640559Phase 1Completed
- Sponsor
- Pharmasyntez
- Start
- May 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in tissue adhesions comparing Seroguard with Placebo (2 arms). Primary endpoint: Number of Participants With Adverse Events at 28 days. Started May 2015; status: completed.
02
Drugs
adezmapimod
03
Conditions
tissue adhesions
Beyond the preview
Go deeper on NCT03640559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640559.